Curran Terrie is a director of Arcutis Biotherapeutics Inc.
Person profile
Roles
Address
New York, New York
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Phathom Pharmaceuticals, Inc.
26 Mar 24
4
Phathom Pharmaceuticals, Inc.
22 Jan 24
4
Phathom Pharmaceuticals, Inc.
3 Nov 23
4
Phathom Pharmaceuticals, Inc.
17 Jul 23
4
Arcutis Biotherapeutics, Inc.
2 Jun 23
4
Phathom Pharmaceuticals, Inc.
7 Apr 23
4
Myovant Sciences Ltd.
10 Mar 23
4
Phathom Pharmaceuticals, Inc.
3 Mar 23
4
Phathom Pharmaceuticals, Inc.
20 Jan 23
4
Phathom Pharmaceuticals, Inc.
23 Nov 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Mar 24 | PHAT Phathom Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 9.11 | 16,851 | 153.51 k | 410,784 |
18 Jan 24 | PHAT Phathom Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 7.6 | 475,000 | 3.61 mm | 475,000 |
1 Nov 23 | PHAT Phathom Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 37,500 | 0.00 | 427,171 |
14 Jul 23 | PHAT Phathom Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 200,000 | 0.00 | 389,671 |
14 Jul 23 | PHAT Phathom Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 39.11 | 225,000 | 8.80 mm | 0 |
14 Jul 23 | PHAT Phathom Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 32.2 | 175,000 | 5.64 mm | 0 |
31 May 23 | ARQT Arcutis Biotherapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 4,375 | 0.00 | 8,687 |
31 May 23 | ARQT Arcutis Biotherapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7.51 | 12,220 | 91.77 k | 12,220 |